Overview
November 1st, 202 DelveInsight Busines Research Releases The global dry powder inhaler devices market was valued at USD 13,935 milion in 2021, growing at a CAGR of 4.58% during the forecast period from 202 to 2027 to reach USD 18,626 milion by 2027. The dry powder inhaler devices market is witnesing a positive growth owing to the various factors such as increasing prevalence of COVID-19, rising prevalence of diabetes, increasing prevalence of asthma, surge in cystic fibrosis cases, surge in prevalence of Chronic Obstructive Pulmonary Diseases (COPD), rise in geriatric population and increase in technological advancements with respect to the product oferings.
Key Information
Therefore, the dry powder inhaler devices market is estimated to grow during the forecast period from 202 to 2027.Some of the key market players operating in the Dry powder inhaler devices market include Boehringer Ingelheim Inc, CHIESI Farmaceutici S.p.A, Cipla Inc, GSK Group of Companies, Hovione, OPKO Health Inc, Teva Pharmaceutical Industries Ltd, Vectura Group Ltd, Radius Inovation & Development, Otsuka Pharmaceutical Co Ltd, RESPIRA THERAPEUTICS INC, ManKind Corporation, Pharmaxis Ltd, Stevanato Group, Haro Höfliger Verpackungsmaschinen GmbH, H&T Prespart Manufacturing Ltd, Catalent Inc, Merxin Ltd, Manta Devices LC, PUREIMS, and among others.
Summary
var scren_width=(navigator.userAgent.match(/iPhone/i) | navigator.userAgent.match(/iPod/i) ? scren.width : window.inerWidth; if (scren_width <= 91) { (function() { var a=",b=[ "adid=medg-medgadget-poster", "site=ehs.pro.medgadget", "size=30x250", "vpos=t", "hpos=r", "zone=", ]; for (var c=0;c<b.length;+c){a+=b[c]+"&"}a+="url="+encodeURIComponent(window.location.href); var x="htps:/ads.ehealthcaresolutions.com/a/?"+a; var y=document.createElement("script");y.type="text/javascript"y.async=true;y.src=x;